Literature DB >> 10932228

Characterization of a newly discovered T-cell receptor beta-chain heterodimer expressed on a CD8+ bone marrow subpopulation that promotes allogeneic stem cell engraftment.

M J Schuchert1, R D Wright, Y L Colson.   

Abstract

The facilitating cell is a rare CD8+ bone marrow subpopulation that can enhance allogeneic hematopoietic stem cell engraftment across complete major histocompatibility complex barriers without inducing acute graft-versus-host disease. Here we describe a CD3epsilon-associated complex on the facilitating cell surface that consists of the T-cell receptor beta-chain disulfide-linked to a previously unknown 33-kilodalton glycoprotein. Provisionally called FCp33, this glycoprotein does not represent any of the known protein chains or surrogates associated with CD3-T-cell receptor beta. Expression of this CD3-T-cell receptor beta-FCp33 complex directly correlates with the facilitating cell's functional ability to enhance allogeneic stem cell engraftment in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932228     DOI: 10.1038/78667

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  13 in total

Review 1.  Tolerance induction for solid organ grafts with donor-derived hematopoietic reconstitution.

Authors:  K L Gandy
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Authors:  L M Pelus; S Fukuda
Journal:  Leukemia       Date:  2007-11-01       Impact factor: 11.528

Review 3.  Peripheral blood stem cell mobilization: new regimens, new cells, where do we stand.

Authors:  Louis M Pelus
Journal:  Curr Opin Hematol       Date:  2008-07       Impact factor: 3.284

4.  Induction of FoxP3+CD4+CD25+ regulatory T cells by a bone marrow population distinct from plasmacytoid-DC.

Authors:  Kendra N Taylor; Monika Laszkowska; Evan Cohick; Yolonda L Colson
Journal:  Cell Immunol       Date:  2008-05-23       Impact factor: 4.868

5.  Neuronal and nonneuronal cholinergic structures in the mouse gastrointestinal tract and spleen.

Authors:  Laurent Gautron; Joseph M Rutkowski; Michael D Burton; Wei Wei; Yihong Wan; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2013-11       Impact factor: 3.215

Review 6.  Stem cell-based therapeutic applications in retinal degenerative diseases.

Authors:  Yiming Huang; Volker Enzmann; Suzanne T Ildstad
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

7.  Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection.

Authors:  Sanja Vodanovic-Jankovic; William R Drobyski
Journal:  Biol Blood Marrow Transplant       Date:  2006-11       Impact factor: 5.742

Review 8.  Evolving approaches of hematopoietic stem cell-based therapies to induce tolerance to organ transplants: the long road to tolerance.

Authors:  J Leventhal; J Miller; M Abecassis; D J Tollerud; S T Ildstad
Journal:  Clin Pharmacol Ther       Date:  2012-10-10       Impact factor: 6.875

9.  Hematopoietic chimerism and central tolerance created by peripheral-tolerance induction without myeloablative conditioning.

Authors:  Edward Seung; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

10.  The chemokine GRObeta mobilizes early hematopoietic stem cells characterized by enhanced homing and engraftment.

Authors:  Seiji Fukuda; Huimin Bian; Andrew G King; Louis M Pelus
Journal:  Blood       Date:  2007-04-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.